C V Rao
University of Louisville
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by C V Rao.
Thrombosis and Haemostasis | 2004
Nelli Baal; Kerstin Reisinger; Henning Jahr; Rainer M. Bohle; Olin D. Liang; Karsten Münstedt; C V Rao; Klaus T. Preissner; Marek Zygmunt
A significant number of hematopoietic stem/progenitor cells (HSPC) in human umbilical cord blood could serve as a reservoir for the placental vasculature, yet, their morphological and functional features are not completely understood. Here, we describe the characterization of purified CD133(+) progenitor cells from umbilical cord blood, a subset of CD34(+) hematopoietic progenitors that were grown in proliferation medium containing Flt3-ligand, thrombopoietin and stem cell factor. Following isolation and enrichment of the CD133(+) cells by immunomagnetic cell sorting, they remained non-adherent for up to 40 days in culture and expressed different pluripotency markers including Sox-1, Sox-2, FGF-4, Rex-1 and Oct-4.Oct-4 expression was confirmed by laser-assisted single cell picking with subsequent quantitative real-time RT-PCR. The expression of Oct-4 indicates a pluripotent phenotype of CD133(+) cells and appears to be of functional relevance: After three weeks in endothelial differentiation medium, suspended cells became adherent, developed an endothelial cell-like morphology, bound fluoresceine isothiocyanate-labeled Ulex europaeus agglutinin-1, took up acetylated Di-LDL, and expressed other endothelial markers such as PECAM-1 or VEGFR-2. Concomitantly, Oct-4 expression was significantly reduced. Moreover, following treatment with retinoic acid, CD133(+) cells exhibited neural morphology associated with the expression of beta-III-tubulin. CD133(+) cells were found to express the luteinizing hormone/human chorionic gonadotropin (LH/hCG) receptor, detected by RT-PCR and immunocytochemistry. The recombinant human chorionic gonadotropin induced proliferation of the CD133(+) cells in a dose-specific manner. Our results indicate that CD133(+) HSPC from umbilical cord blood may have a greater differentiation potential than previously recognized and give rise to proliferative endothelial cells participating in placental vasculogenesis.
The Journal of Clinical Endocrinology and Metabolism | 2002
Marek Zygmunt; Friederike Herr; Stefanie Keller-Schoenwetter; Karin Kunzi-Rapp; Karsten Münstedt; C V Rao; Uwe Lang; Klaus T. Preissner
The Journal of Clinical Endocrinology and Metabolism | 1996
J E Pabon; X. Li; Z.M. Lei; Joseph S. Sanfilippo; Marvin A. Yussman; C V Rao
The Journal of Clinical Endocrinology and Metabolism | 1994
P Toth; X. Li; C V Rao; S R Lincoln; J. S. Sanfilippo; J. A. Spinnato; M. A. Yussman
The Journal of Clinical Endocrinology and Metabolism | 1993
Z.M. Lei; P Toth; C V Rao; D. Pridham
Endocrinology | 1996
S W Han; Z.M. Lei; C V Rao
The Journal of Clinical Endocrinology and Metabolism | 1994
J Lin; Z.M. Lei; S Lojun; C V Rao; P G Satyaswaroop; T G Day
The Journal of Clinical Endocrinology and Metabolism | 1994
J Zuo; Z.M. Lei; C V Rao; M Pietrantoni; V D Cook
The Journal of Clinical Endocrinology and Metabolism | 2003
Mark O. Goodarzi; David W. Dawson; Xian Li; Zhenmin Lei; Peter Shintaku; C V Rao; Andre J. Van Herle
The Journal of Clinical Endocrinology and Metabolism | 2006
Karla Saner-Amigh; Bobbie Mayhew; Franco Mantero; Francesca Schiavi; Perrin C. White; C V Rao; William E. Rainey